Analysis of Plasma Cell-Free DNA by Ultradeep Sequencing in Patients With Stages I to III Colorectal CancerThomas Reinert, Claus L. Andersen, Samantha Navarro et al.|JAMA Oncology|2019Cited by 992
The effect of surgical trauma on circulating free DNA levels in cancer patients—implications for studies of circulating tumor DNATenna Vesterman Henriksen, Claus L. Andersen, Thomas Reinert et al.|Molecular Oncology|2020Cited by 157
Ultrasensitive plasma-based monitoring of tumor burden using machine-learning-guided signal enrichmentAdam J. Widman, Catherine Potenski, Minita Shah et al.|Nature Medicine|2024Cited by 95
Unraveling the potential clinical utility of circulating tumor DNA detection in colorectal cancer—evaluation in a nationwide Danish cohortTenna Vesterman Henriksen, Claus L. Andersen, Christina Demuth et al.|Annals of Oncology|2023Cited by 71
IMPROVE-IT2: implementing noninvasive circulating tumor DNA analysis to optimize the operative and postoperative treatment for patients with colorectal cancer – intervention trial 2. Study protocolJesper Nors, Claus L. Andersen, Tenna Vesterman Henriksen et al.|Acta Oncologica|2020Cited by 46